Citation: Qi Luo, Yunwei Zhang, Zihua Wang, Yining Sun, Linqing Shi, Yue Yu, Jiyun Shi, Zhiyuan Hu, Fan Wang. A novel peptide-based probe ^99mTc-PEG₆-RD-PDP2 for the molecular imaging of tumor PD-L2 expression[J]. Chinese Chemical Letters, ;2022, 33(7): 3497-3501. doi: 10.1016/j.cclet.2022.02.068 shu

A novel peptide-based probe ^99mTc-PEG₆-RD-PDP2 for the molecular imaging of tumor PD-L2 expression

Qi Luo ^{a, 1} ,
Yunwei Zhang ^{b, 1} ,
Zihua Wang ^{c, 1} ,
Yining Sun ^d ,
Linqing Shi ^b ,
Yue Yu ^d ,
Jiyun Shi ^{d, *,} ,
Zhiyuan Hu ^{c, e, *,} ,
Fan Wang ^{a, b, d, *,}

a.
Guangzhou Laboratory, Guangzhou 510005, China
b.
Medical Isotopes Research Center and Department of Radiation Medicine, State Key Laboratory of Natural and Biomimetic Drugs, School of Basic Medical Sciences, Peking University, Beijing 100191, China
c.
Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China
d.
Key Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
e.
CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing 100190, China

shijiyun@ibp.ac.cn

huzy@nanoctr.cn

wangfan@bjmu.edu.cn

Received Date: 23 December 2021
Revised Date: 25 February 2022
Accepted Date: 25 February 2022
Available Online: 1 March 2022

Figures(5)

Tumor-related PD-L2 expression is associated with the clinical efficacy of PD-1/PD-L1 blockade therapy. PD-L2-specific imaging can help selecting patients for appropriate immunotherapy. In this study, a PD-L2-targeting peptide (PDP2) was screened by the one-bead one-compound combinatorial library approach. Using the retro-inverso D-peptide of PDP2 (RD-PDP2) and PEGylation strategies, we developed a novel Tc-99m-labeled PD-L2-targeting peptide as a SPECT tracer (^99mTc-PEG₆-RD-PDP2) for imaging of tumor PD-L2 expression. The radiolabeling yield of ^99mTc-PEG₆-RD-PDP2 was greater than 95% by the standard HYNIC/tricine/TPPTS labeling procedure. ^99mTc-PEG₆-RD-PDP2 displayed high PD-L2-binding specificity both in vitro and in vivo. SPECT/CT imaging with ^99mTc-PEG₆-RD-PDP2 showed that the A549-PD-L2 tumors were clearly visualized, whereas the signals in PD-L2-negative A549 tumors were much lower. In vivo blocking study suggested that the tumor uptake of ^99mTc-PEG₆-RD-PDP2 was PD-L2 specifically mediated. ^99mTc-PEG₆-RD-PDP2 is a promising SPECT probe for the non-invasive imaging of tumor PD-L2 expression and has a great potential in guiding the anti-PD-1 or anti-PD-L1 immunotherapy of cancer.
- PD-L2,
- Peptide probe,
- SPECT imaging,
- Immunotherapy
1. [1]
  R.S. Herbst, J.C. Soria, M. Kowanetz, et al., Nature 515 (2014) 563-567. doi: 10.1038/nature14011
2. [2]
  S.M. Ansell, A.M. Lesokhin, I. Borrello, et al., N. Engl. J. Med. 372 (2015) 311-319. doi: 10.1056/NEJMoa1411087
3. [3]
  A. Haslam, V. Prasad, J.A.M.A. Netw. Open 2 (2019) e192535-e192543. doi: 10.1001/jamanetworkopen.2019.2535
4. [4]
  N. Wan, T.T. Zhang, S.H. Hua, et al., Cancer Med. 9 (2020) 1683-1693. doi: 10.1002/cam4.2793
5. [5]
  Q. Chen, T. Li, W. Yue, Onco Targets ther. 11 (2018) 4673. doi: 10.2147/OTT.S168313
6. [6]
  M. Yi, D. Jiao, H. Xu, et al., Mol. cancer 17 (2018) 1-14.
7. [7]
  A.V. Balar, D. Castellano, P.H. O'Donnell, et al., Lancet Oncol. 18 (2017) 1483-1492. doi: 10.1016/S1470-2045(17)30616-2
8. [8]
  E.G. Leprieur, C. Dumenil, C. Julie, et al., Eur. J. Cancer 78 (2017) 16-23. doi: 10.1016/j.ejca.2016.12.041
9. [9]
  L.Q. Chow, R. Haddad, S. Gupta, et al., J. Clin. Oncol. 34 (2016) 3838-3845. doi: 10.1200/JCO.2016.68.1478
10. [10]
  R.J. Motzer, B. Escudier, D.F. McDermott, et al., N. Engl. J. Med. 373 (2015) 1803-1813. doi: 10.1056/NEJMoa1510665
11. [11]
  D.P. Carbone, M. Reck, L. Paz-Ares, et al., N. Engl. J. Med. 376 (2017) 2415-2426. doi: 10.1056/NEJMoa1613493
12. [12]
  P. Sharma, M.K. Callahan, P. Bono, et al., Lancet Oncol. 17 (2016) 1590-1598. doi: 10.1016/S1470-2045(16)30496-X
13. [13]
  H. Wang, H. Yao, C. Li, et al., Oncoimmunology 6 (2017) e1327494-e1327504. doi: 10.1080/2162402X.2017.1327494
14. [14]
  H. Yang, X. Zhou, L. Sun, Y. Mao, Front. Oncol. 9 (2019) 47-58. doi: 10.3389/fonc.2019.00047
15. [15]
  J. Liu, H. Li, L. Sun, Y. Yuan, C. Xing, Biomed. Res. Int. 2020 (2020) 2496582-2496592.
16. [16]
  Y. Yang, X. Wang, Y. Bai, et al., Urol. Oncol. 38 (2020) 603. e609-603. e615.
17. [17]
  Y.R. Miao, K.N. Thakkar, J. Qian, et al., Clin. Cancer Res. 27 (2021) 4435-4448. doi: 10.1158/1078-0432.ccr-20-0482
18. [18]
  P. Youngnak, Y. Kozono, H. Kozono, et al., Biochem. Biophys. Res. Commun. 307 (2003) 672-677. doi: 10.1016/S0006-291X(03)01257-9
19. [19]
  Y. Latchman, C.R. Wood, T. Chernova, et al., Nat. Immunol. 2 (2001) 261-268. doi: 10.1038/85330
20. [20]
  D.M. Pardoll, Nat. Rev. Cancer 12 (2012) 252-264. doi: 10.1038/nrc3239
21. [21]
  T. Tanegashima, Y. Togashi, K. Azuma, et al., Clin. Cancer Res. 25 (2019) 4808-4819. doi: 10.1158/1078-0432.ccr-18-3991
22. [22]
  J.H. Yearley, C. Gibson, N. Yu, et al., Clin. Cancer Res. 23 (2017) 3158-3167.
23. [23]
  S.C. Liang, Y.E. Latchman, J.E. Buhlmann, et al., Eur. J. Immunol. 33 (2003) 2706-2716. doi: 10.1002/eji.200324228
24. [24]
  K. Broos, Q. Lecocq, G. Raes, et al., Theranostics 8 (2018) 3559-3570. doi: 10.7150/thno.24762
25. [25]
  Z. Wang, W. Wang, X. Bu, et al., Anal. Chem. 87 (2015) 8367-8372. doi: 10.1021/acs.analchem.5b01588
26. [26]
  W. Wang, M. Li, Z. Wei, et al., Anal. Chem. 86 (2014) 3703-3707. doi: 10.1021/ac500465e
27. [27]
  L. Li, Y. Wu, Z. Wang, et al., J. Nucl. Med. 58 (2017) 821-826. doi: 10.2967/jnumed.116.183863
28. [28]
  M. Seia, E. Zisman, FASEB J. 11 (1997) 449-456. doi: 10.1096/fasebj.11.6.9194525
29. [29]
  R. Tugyi, K. Uray, D. Iván, et al., Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 413-418. doi: 10.1073/pnas.0407677102
30. [30]
  B. Jia, J. Shi, Z. Yang, et al., Bioconjug. Chem. 17 (2006) 1069-1076. doi: 10.1021/bc060055b
31. [31]
  Q. Luo, G. Yang, H. Gao, et al., Bioconjug. Chem. 31 (2020) 1510-1521. doi: 10.1021/acs.bioconjchem.0c00170
1. [1]
  Meng Sun , Jiazhen Yang , Leijiao Li , Yunhui Li , Wenliang Li , Jianxun Ding . Engineered bacteria potentiate cancer immunotherapy. Chinese Chemical Letters, 2025, 36(9): 111093-. doi: 10.1016/j.cclet.2025.111093
2. [2]
  Xiaofang Luo , Ye Wu , Xiaokun Zhang , Min Tang , Feiye Ju , Zuodong Qin , Gregory J Duns , Wei-Dong Zhang , Jiang-Jiang Qin , Xin Luan . Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters, 2025, 36(1): 109724-. doi: 10.1016/j.cclet.2024.109724
3. [3]
  Liangliang Jia , Ye Hong , Xinyu He , Ying Zhou , Liujiao Ren , Hongjun Du , Bin Zhao , Bin Qin , Zhe Yang , Di Gao . Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters, 2025, 36(2): 109957-. doi: 10.1016/j.cclet.2024.109957
4. [4]
  Shuang Liang , Jianjun Yao , Dan Liu , Mengli Zhou , Yong Cui , Zhaohui Wang . Tumor-responsive covalent organic polymeric nanoparticles enhancing STING activation for cancer immunotherapy. Chinese Chemical Letters, 2025, 36(3): 109856-. doi: 10.1016/j.cclet.2024.109856
5. [5]
  Yuequan Wang , Congtian Wu , Chengcheng Feng , Qin Chen , Zhonggui He , Shenwu Zhang , Cong Luo , Jin Sun . Spatiotemporally-controlled supramolecular hybrid nanoassembly enabling ferroptosis-augmented photodynamic immunotherapy of cancer. Chinese Chemical Letters, 2025, 36(3): 109902-. doi: 10.1016/j.cclet.2024.109902
6. [6]
  Yanjun Cai , Yong Jiang , Yu Chen , Erzhuo Cheng , Yuan Gu , Yuwei Li , Qianqian Liu , Jian Zhang , Jifang Liu , Shisong Han , Bin Yang . Amplifying STING activation and immunogenic cell death by metal-polyphenol coordinated nanomedicines for enhanced cancer immunotherapy. Chinese Chemical Letters, 2025, 36(5): 110437-. doi: 10.1016/j.cclet.2024.110437
7. [7]
  Donghu Yu , Junneng Wang , Lei Hu , Youxian Wu , Tianqing Wang , Zhiyu Li , Zefen Wang , Qihang Ding , Yao Sun , Zhiqiang Li . Knowledge structures and research hotspots of immunotherapy for brain metastasis, glioma, meningioma, and pituitary adenoma: A bibliometric and visualization review. Chinese Chemical Letters, 2025, 36(12): 110995-. doi: 10.1016/j.cclet.2025.110995
8. [8]
  Chenlu Huang , Xinyu Yang , Qingyu Yu , Linhua Zhang , Dunwan Zhu . Gas-generating polymersomes-based amplified photoimmunotherapy for abscopal effect and tumor metastasis inhibition. Chinese Chemical Letters, 2024, 35(6): 109680-. doi: 10.1016/j.cclet.2024.109680
9. [9]
  Junjie Wang , Yan Wang , Zhengdong Li , Changqiang Xie , Musammir Khan , Xingzhou Peng , Fabiao Yu . Triphenylamine-AIEgens photoactive materials for cancer theranostics. Chinese Chemical Letters, 2024, 35(6): 108934-. doi: 10.1016/j.cclet.2023.108934
10. [10]
  Xinyue Lan , Junguang Liang , Churan Wen , Xiaolong Quan , Huimin Lin , Qinqin Xu , Peixian Chen , Guangyu Yao , Dan Zhou , Meng Yu . Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters, 2024, 35(4): 108616-. doi: 10.1016/j.cclet.2023.108616
11. [11]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
12. [12]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619
13. [13]
  Weiqian Jin , Lin Liao , Tao Qin , Xiaoxuan Guan , Huyang Gao , Peng Liang , Ming Gao , Junyu Lu . Recent advances in nanomedicine therapy for bacterial pneumonia. Chinese Chemical Letters, 2025, 36(6): 110920-. doi: 10.1016/j.cclet.2025.110920
14. [14]
  Rongrong Zheng , Zuxiao Chen , Qiuyuan Li , Ni Yang , Wenjun Zhang , Chuyu Huang , Linping Zhao , Xin Chen , Hong Cheng , Shiying Li . Endoplasmic reticulum targeting photodynamic oxidizer to boost anti-tumor immunity by intensifying immunogenic cell death in conjunction with IDO1 inhibition. Chinese Chemical Letters, 2025, 36(12): 110865-. doi: 10.1016/j.cclet.2025.110865
15. [15]
  Ying Sun , Minglong Chen , Ying Chen , Wanchen Zhao , Yanping Fu , Zhengwei Huang , Chao Lu , Chuanbin Wu , Xin Pan , Guilan Quan . Dissolving microneedle-assisted in situ cancer vaccine combined with cytolytic peptide for anti-melanoma immunotherapy. Chinese Chemical Letters, 2025, 36(12): 110908-. doi: 10.1016/j.cclet.2025.110908
16. [16]
  Kun Chen , Huimin Lin , Xin Peng , Ziying Wu , Jingyue Dai , Yi Sun , Yaxuan Feng , Ziyi Huang , Zhiqiang Yu , Meng Yu , Guangyu Yao , Jigang Wang . In situ synthesis of MnO₂ micro/nano-adjuvants for enhanced immunotherapy of breast tumors. Chinese Chemical Letters, 2025, 36(5): 110045-. doi: 10.1016/j.cclet.2024.110045
17. [17]
  Shuyu Liu , Xiaomin Sun , Bohan Song , Gaofeng Zeng , Bingbing Du , Chongshen Guo , Cong Wang , Lei Wang . Design and Fabrication of Phospholipid-Vesicle-based Artificial Cells towards Biomedical Applications. University Chemistry, 2024, 39(11): 182-188. doi: 10.12461/PKU.DXHX202404113
18. [18]
  Gongcheng Ma , Qihang Ding , Yuding Zhang , Yue Wang , Jingjing Xiang , Mingle Li , Qi Zhao , Saipeng Huang , Ping Gong , Jong Seung Kim . Palladium-free chemoselective probe for in vivo fluorescence imaging of carbon monoxide. Chinese Chemical Letters, 2024, 35(9): 109293-. doi: 10.1016/j.cclet.2023.109293
19. [19]
  Zhihui Zhang , Ru Sun , Chong Bian , Hongbo Wang , Zhen Zhao , Panpan Lv , Jianzhong Lu , Haixin Zhang , Hulie Zeng , Yuanyuan Chen , Zhijuan Cao . A dual-protease-triggered chemiluminescent probe for precise tumor imaging. Chinese Chemical Letters, 2025, 36(2): 109784-. doi: 10.1016/j.cclet.2024.109784
20. [20]
  Qian Pang , Fangjun Huo , Yongkang Yue , Caixia Yin . ONOO⁻ and viscosity dual-response fluorescent probe for arthritis imaging in vivo. Chinese Chemical Letters, 2025, 36(9): 110713-. doi: 10.1016/j.cclet.2024.110713

Get Citation

PDF

XML

Metrics

PDF Downloads(2)
Abstract views(1590)
HTML views(38)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

A novel peptide-based probe 99mTc-PEG6-RD-PDP2 for the molecular imaging of tumor PD-L2 expression

Metrics

通讯作者: 陈斌, bchen63@163.com

A novel peptide-based probe ^99mTc-PEG₆-RD-PDP2 for the molecular imaging of tumor PD-L2 expression